New York Times columnist and former Nixon speechwriter William Safire is the latest prominent conservative to endorse embryonic stem cell research. Yesterday, Safire devoted his column to his hope that former president Ronald Reagan’s long battle with Alzheimer’s may help to break the impasse blocking greater federal support of research into the cells and their potential to help millions of American’s including those with Alzheimer’s.
Safire cogently argues that
this research, whether the government likes it or not, is growing apace. Unless we act now to direct it toward morally acceptable ends–cure and treatment of disease and the extension of active life, not monstrous manipulation and production of clones for spare parts–we risk losing the imperfectability that makes us human.
This is the point that many opponents of stem cell research miss: that by not funding embryonic stem cell research, which will continue regardless, the federal government misses its chance to effectively shape and regulate the direction that research takes.
The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.